A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis

Temozolomide (TMZ) is the first-line chemotherapy drug that has been used to treat glioma for over a decade, but the benefits are limited by half of the treated patients who acquired resistance. Studies have shown that glioma TMZ resistance is a complex process with multiple factors, which has not b...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Oncol
Main Authors: Hu, Zhifang, Mi, Yajing, Qian, Huiming, Guo, Na, Yan, Aili, Zhang, Yuelin, Gao, Xingchun
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Oncology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7324762/
https://ncbi.nlm.nih.gov/pubmed/32656078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00897
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker